NEWS & EVENTS
-
[NEWS] June. 2020.Researchers at UCSD School of Medicine have used induced pluripotent stem cells (iPSCs) and deleting a key gene to create NK cells against leukemia both in vivo and in vitro.DOI:https://doi.org/10.1016/j.stem.2020.05.008 -
[NEWS] April. 2020. Citius Signs exclusive option with Novellus to license Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) associated with COVID-19. -
【EVENT】Mar. 2020. Conrad General Manager and Chief Science Officer visited China Medical University Hospital of Taiwan for the exchange of experience on building cell processing units and the fulfilment of guidelines for inspection. -
【EVENT】Feb. 2020. Conrad noted COVID-19 pandemic and the successful controls on the virus prevention, and decided to boost cooperation with pharma industries in Taiwan. -
【EVENT】Jan. 2020. Osaka University transplants iPS cell-based heart cells in world's first clinical trial. -
【EVENT】Sep. 30-Oct 1, 2019. Conrad General Manager attended 2019 ISPE Asia Pacific Pharmaceutical Manufacturing Conference, and vowed to contribute to the regulations of pharma industry. -
【EVENT】Sep. 2019. Conduct a 3-year project of galectin-9 development and entered a sponsor research agreement with University of Texas MD Anderson Cancer Center. -
【EVENT】Aug. 2019. Seeking Creative Biolabs Inc. as CRO services for filing investigational research to USFDA.